SMS service for awareness on cheaper drugs:
Sep 1, 2012, 12.59PM IST, The writer has posted comments on this article PTI
NEW
DELHI: The Department of Pharmaceuticals in the Ministry of Chemicals
and Fertilisers is planning to launch a SMS service providing
information about affordable alternatives to medicines prescribed by
doctors.The Short Message Service (SMS) facility could help poor
patients find cheaper alternatives to medicines prescribed by doctors.
The
Ministry of Health and Family Welfare has sought that all 348 drugs
listed in the National List of Essential Medicines, 2011 should be
brought within the purview of the Drug Price Control Order (DPCO) so
that there should be minimum impact on the expenses of consumer.
Link : http://timesofindia.indiatimes.com/tech/enterprise-it/services-apps/SMS-service-for-awareness-on-cheaper-drugs-in-the-offing/articleshow/16125680.cmsNPPA has initiated a process to end the freedom enjoyed by drug makers to fix the retail price of their imported medicines |
Pricing of imported drugs under regulatory scanner:
6 Sep, 2012,07.38AM IST, The writer has posted comments on this article Khomba SinghKhomba Singh,ET Bureau
India's
drug price regulator has initiated a process to end the 16-year freedom
enjoyed by foreign drug makers to fix the retail price of their
imported medicines in the country.
The National Pharmaceutical
Pricing Authority has written to the department of
pharmaceuticals to amend the Drugs (Prices Control) Order of 1995, its
chairman CP Singh told ET.
"There
is an impression among some quarters that some companies are launching
their drugs in India by declaring a much higher price (than cost of the
drug)," Singh said. "We want to have some control over this in public
interest. Today, we are completely blind how they have arrived at the
landed price."
Singh said verification will help the regulator understand if the MRP in India is near the actual price (cost) of the drug.
Last
year, NPPA tried to seek such details from some foreign drug makers.
But its request was shot down by the Delhi High Court after the law
ministry conceded that NPPA had no such powers under DPCO.
Local
companies also say this rule is unfair to them as their MRP is fixed
after strict scrutiny of the cost of production by NPPA, while no such
rule is applicable to imported brands. "We want a level playing field
based on a common ceiling price for a product to encourage domestic
manufacturers by ensuring that imported products do not get an unfair
advantage," said Rakesh Bamzai, president (marketing), at Biocon.
Link : http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/pharmaceuticals/pricing-of-imported-drugs-under-regulatory-scanner/articleshow/16274253.cms
HC notice to Centre on generic drugs
Sep 11, 2012, 07.04 AM IST, The writer has posted comments on this articleTNN
The
petitioner has sought direction to pharmaceutical department of
ministry of chemicals and fertilisers as well as National Pharmaceutical
Pricing Authority to take effective steps to control prices of generic
medicines so that they could come within reach of the common man.
The
ministry of corporate affairs conducted a study on non-scheduled drugs
manufactured and marketed by leading pharmaceutical companies in the
country and found that the profit margins were exorbitantly high.
The
ministry wrote on June 12, 2012 to the ministry of health and family
welfare as well as ministry of chemical and fertilisers for taking
action in the matter but till date nothing has been done, said the
petition.
Link : http://timesofindia.indiatimes.com/city/lucknow/HC-notice-to-Centre-on-generic-drugs/articleshow/16346263.cms
Pharma GoM finalises pricing policy, to cover 348 drugs
Thu, Sep 27, 2012 at 18:45A ministers panel, headed by Agriculture Minister Sharad Pawar, finalised the pharma pricing policy under which 348 essential drugs will come under price control of the government.
The Group of
Ministers (GoM) will be sending their recommendations to the Cabinet for
approval to bring drugs in National List of Essential Medicines (NLEM),
that have a total sales of around Rs 29,000 crore, which is about 60
percent of the domestic market, under control.
At present, the
government through the National Pharmaceutical Pricing Authority (NPPA),
controls prices of 74 bulk drugs and their formulations.
Link : http://www.moneycontrol.com/news/business/pharma-gom-finalises-pricing-policy-to-cover-348-drugs_762652.html#toptag
Reference News Link
All of these posts were incredible perfect. It would be great if you’ll post more updates.
ReplyDeletecompany formation hong kong